Packaged Oxygen Market Trends & Forecast According to a research study published by Knowledge Sourcing Intelligence (KSI), the packaged oxygen market will expand f...

Packaged Oxygen Market Trends & Forecast
According to a research study published by Knowledge Sourcing Intelligence (KSI), the packaged oxygen market will expand from USD 1,572.85 billion in 2025 to USD 2,031.09 billion in 2030 at a CAGR of 5.25% during the forecast period.Packaged oxygen refers to oxygen that is compressed in liquid, gas, or solid-state and is enclosed in a container. Its use in the health sector was the first market that propelled the product, but now it has been employed in various industrial processes. Oxygen is a non-metallic, odourless gas, which is one of the essential things in the ecosystem and is used in several industries, medicines, and sciences. The demand for packaged oxygen has risen gradually as the need for oxygen in industrial applications has also increased. The number of people demanding packaged oxygen for home care is increasing because of the rising concern over air pollution. Moreover, this has been a huge addition to the demand for packaged oxygen in every industry that is using it. The major respiratory diseases listed in the WHO report are lung cancer, COPD, asthma, acute lower respiratory tract infections, and tuberculosis. As a result, the medical sector has become a major consumer of the product, thus the market has been extended. The dangerous increase in air pollution is one of the factors pushing up demand, as well.
Get In-Depth Analysis of the Global Packaged Oxygen Market
This article covers the fundamentals. Our full market report provides the granular data, competitive landscape, and strategic insights you need to navigate the global packaged oxygen industry.- ? Detailed Market Size & Growth Forecasts to 2030
- ? Segment-wise Breakdown (Medical vs Industrial)
- ? Regional Demand Hotspots & Emerging Opportunities
Packaged Oxygen Market Report Highlights
- During the forecast period, the medical oxygen sector is expected to become a rapidly changing area in the overall global packaged oxygen market. Rising incidences of respiratory diseases such as chronic obstructive pulmonary disease (COPD), asthma, and COVID-19-related complications have contributed significantly to the growth of this segment, as they have resulted in an increased need for oxygen therapy due to the awareness raised. Besides that, the growth of healthcare facilities in the developing areas, the increase of home care services and the use of portable oxygen cylinders are the factors that are boosting this segment further.
- Among the end-users, the hospital segment is likely to have the maximum growth rate in the packaged oxygen market. Hospitals continue to be the major buyers of packaged oxygen as they require the use of very pure oxygen in operations, intensive care units, and emergency care. The rising number of hospitals, mainly in developing countries, as well as the refurbishment of already existing healthcare facilities, is contributing to the increase in demand.
- The need for packaged oxygen has been on the rise in diverse industries in the Asia-Pacific. Such a demand increase can be explained by many factors that influence various industries, like hospitals, healthcare settings, and home care, due to the increased investment in health systems and the effect of rapid urbanisation. Advancing the geriatric population trend is considerably raising the demand for medical oxygen, mainly in Japan.
Report Coverage:
| Report Metric | Details |
| Packaged Oxygen Market Size in 2025 | US$1,572.85 billion |
| Packaged Oxygen Market Size in 2030 | US$2,031.09 billion |
| Growth Rate | CAGR of 5.25% |
| Drivers |
|
| Restraints |
|
| Segmentation |
|
| List of Major Companies in Packaged Oxygen Market |
|
Packaged Oxygen Market Growth Drivers and Restraints
Growth Drivers:- Regulatory Support and Initiatives: The market is expanding with the help of government programs and laws that encourage the inflow of money, lower the cost of getting into the business, and foster innovation in the packaged oxygen sector.
- Increasing Technological Advancement: Technology changes and innovations have been at the forefront of the packaged oxygen market to remain relevant with the developing changes in the market.
- High Production and Storage Costs: Producing oxygen of very high purity requires quite expensive separation, compression, and purification processes.
- Supply Chain and Distribution Challenges: It is a big logistical challenge to transport packaged oxygen safely over long distances.
Packaged Oxygen Market Key Development
- Collaboration: In August 2025, GC-TPN FlexPak-W&H created a novel flexible packaging solution called Mono Material MDOPE Film with exceptional oxygen barrier qualities.
- Initiative: In April 2025, WHA established a new Oxygen Equipment Supplier Certification Program to ensure industry best practices in oxygen service and fire risk reduction.
Packaged Oxygen Market Segmentation
Knowledge Sourcing Intelligence has segmented the Global Packaged Oxygen Market based on oxygen type, end-user, and region: Packaged Oxygen Market, By Oxygen Type- Medical Oxygen
- Industrial Oxygen
- Hospitals
- Industries
- Others
- North America
- USA
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Others
- Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Others
- South America
- Brazil
- Argentina
- Others
- Middle East and Africa (MEA)
- Saudi Arabia
- UAE
- Others
Packaged Oxygen Market Key Players
- Oxy99
- Messer Group GmbH
- Leeden National Oxygen Ltd.
- Vitality Air
- The Linde Group
- Gupta Oxygen Pvt Ltd.
- Oxygen Plus. Inc.
- Boost Oxygen, LLC
- Wild Goose Filling
- Gaztron Engineering
- Gulf Cryo
- Matheson
- GENERON
- JSC Grasys
- Air Liquide
About Knowledge Sourcing Intelligence (KSI)
Knowledge Sourcing Intelligence (KSI) is a market research and consulting firm headquartered in India. Backed by seasoned industry experts, we offer syndicated reports, customized research, and strategic consulting services. Our proprietary data analytics framework, combined with rigorous primary and secondary research, enables us to deliver high-quality insights that support informed decision-making.Go from Insight to Action with Our Market Research
You've seen the overview. Now, get the detailed data and strategic analysis you need to stay ahead in the gases and healthcare market. Explore our related, in-depth reports. Each report includes comprehensive data, forecasts, and competitive analysis to empower your business decisions.Need specialized data cuts or competitive intelligence?
Our analyst team provides bespoke market sizing, supplier audits, and country-level feasibility reports tailored to your enterprise roadmap.
Speak With an Industry Analyst βAsk an Industry Analyst
Have questions regarding this briefing or market projections? Inquire with our sector lead.
Related Press Releases
View All β
ADC Manufacturing & CDMO Market is expected to reach USD 10.49 billion by 2031
Aug 7, 2026
Lifestyle-Associated Cancer Epidemiology Market is expected to reach USD 13.12 billion by 2031
Aug 5, 2026
Psycho-Oncology Digital Health Market is anticipated to surpass USD 290.01 million in 2031 at a CAGR of 8.5%
Jul 30, 2026
Intratumoral Injection Therapy Market is expected to reach USD 630.39 million by 2031
Jul 24, 2026
Palliative Care in Oncology Market is expected to reach USD 244.1 billion by 2031
Jul 22, 2026More Press Releases
Oncology Drug Resistance Testing Market is projected to reach USD 3.41 billion in 2031 at a CAGR of 6.6 %
The oncology drug resistance testing market is expanding due to rising cancer prevalence, increasing drug resistance, and growing adoption of precision oncology. Advances in NGS-based testing, companion diagnostics, and targeted therapies, alongside FDA approvals and investments in personalized medicine, are accelerating demand for effective resistance monitoring across hospitals and clinical diagnostics worldwide.
TROP-2 Targeted Therapy Market is anticipated to surpass USD 3.29 billion in 2031 at a CAGR of 8.6 %
The TROP-2 Targeted Therapy market is expanding rapidly due to increasing precision oncology adoption, rising cancer prevalence, and growing use of antibody-drug conjugates. North America leads the market, while Asia Pacific shows the fastest growth. Continuous clinical trials, regulatory approvals, and strategic collaborations are accelerating innovation and commercial adoption worldwide.
Second Primary Cancer Prevention Market is expected to reach USD 24.7 billion by 2031
The Second primary cancer prevention refers to strategies aimed at reducing the risk of developing a new, unrelated cancer in individuals with a prior cancer diagnosis. Growing cancer survivorship, advances in treatment, and increasing awareness of long-term health outcomes have heightened the importance of prevention and surveillance programs. Key approaches include routine screening, genetic risk assessment, lifestyle modification, and long-term follow-up care. Government agencies and healthcare organisations increasingly emphasise survivorship care plans and evidence-based screening protocols to detect new malignancies at earlier stages. Continued investments in early detection technologies and personalised risk assessment are expected to support advancements in second primary cancer prevention.